510(k) Report

510(k) · Cleared

Cleared

AXIOS Stent and Electrocautery-Enhanced Delivery System

K220112510(k) TraditionalCleared Sep 7, 2022237-day reviewClass II21 CFR 876.5015

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific Corporation · PCU Pancreatic Stent, Covered, Metallic, Removable

Cleared on Sep 7, 2022 as substantially equivalent to K181905 (Boston Scientific Corporation, 2019) and 1 other predicate after a 237-day review. Its family tree reaches back 9 generations to 1997. 1 later device descends from it.

Decided
Sep 7, 2022
Review
237 days
Class
Class II
Product code
PCU
Recalls
None
Predicates
2

Its longest line of descent runs back 9 generations to K970053 (1997). 13 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 9 generations backK970053 UltratomerxBoston Scientific Corp · 1997
  2. 5 generations between
  3. 3 generations backK163272 AXIOS Stent and Electrocautery Enhanced Delivery SystemBoston Scientific Corporation · 2017
  4. 2 generations backK181905 AXIOS Stent and Delivery System, AXIOS Stent and Electrocautery…Boston Scientific Corporation · 2019 · Recalled
  5. 1 generation backK192043 AXIOS Stent and Electrocautery Enhanced Delivery SystemBoston Scientific Corporation · 2019
  6. This deviceK220112 AXIOS Stent and Electrocautery-Enhanced Delivery SystemBoston Scientific Corporation · 2022
  7. Descendant · cites it directly · 0 of its ownK252648 Niti-S SPAXUS StentTaewoong Medical Co., Ltd. · 2026
Show all 9 generations
  1. Root · 9 generations backK970053 UltratomerxBoston Scientific Corp · 1997
  2. 8 generations backK013153 Autotome RX Model # 4515, 4516Boston Scientific Corp · 2001 · Recalled
  3. 7 generations backK022595 Wilson-Cook CystotomeWilson-Cook Medical, Inc. · 2002
  4. 6 generations backK150692 AXIOS Stent with Electrocautery Enhanced Delivery SystemBoston Scientific Corp · 2015
  5. 5 generations backK152572 AXIOS Stent and Delivery SystemBoston Scientific Corporation · 2015
  6. 4 generations backK153088 AXIOS Stent with Delivery System, AXIOS Stent with Electro-cautery…Boston Scientific Corporation · 2015
  7. 3 generations backK163272 AXIOS Stent and Electrocautery Enhanced Delivery SystemBoston Scientific Corporation · 2017
  8. 2 generations backK181905 AXIOS Stent and Delivery System, AXIOS Stent and Electrocautery…Boston Scientific Corporation · 2019 · Recalled
  9. 1 generation backK192043 AXIOS Stent and Electrocautery Enhanced Delivery SystemBoston Scientific Corporation · 2019
  10. This deviceK220112 AXIOS Stent and Electrocautery-Enhanced Delivery SystemBoston Scientific Corporation · 2022

Most influential descendants

Showing 1 of 1 · See all
  • K252648Niti-S SPAXUS StentTaewoong Medical Co., Ltd. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K970053UltratomerxBoston Scientific Corp1997—
−8K013153Autotome RX Model # 4515, 4516Boston Scientific Corp200132
−7K022595Wilson-Cook CystotomeWilson-Cook Medical, Inc.2002—
−6K150692AXIOS Stent with Electrocautery Enhanced Delivery SystemBoston Scientific Corp2015—
−5K152572AXIOS Stent and Delivery SystemBoston Scientific Corporation2015—
−4K153088AXIOS Stent with Delivery System, AXIOS Stent with Electro-cautery Enhanced…Boston Scientific Corporation2015—
−3K163272AXIOS Stent and Electrocautery Enhanced Delivery SystemBoston Scientific Corporation2017—
−2K181905AXIOS Stent and Delivery System, AXIOS Stent and Electrocautery Enhanced…Boston Scientific Corporation20198
−1K192043AXIOS Stent and Electrocautery Enhanced Delivery SystemBoston Scientific Corporation2019—
0 (this device)K220112AXIOS Stent and Electrocautery-Enhanced Delivery SystemBoston Scientific Corporation2022—
+1K252648Niti-S SPAXUS StentTaewoong Medical Co., Ltd.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199720
201310
201410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K220112, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PCU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PCU device

  1. #1 K252648 Niti-S SPAXUS Stentscore 13.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K181905AXIOS Stent and Delivery System, AXIOS Stent and Electrocautery Enhanced Delivery System
Summary page 4
…Electrocautery-Enhanced Delivery System 510(k) Numbers: K181905, K192043 Device Common Name: Pancreatic drainage stent and delivery system &…
Boston Scientific Corporation20198
*K192043AXIOS Stent and Electrocautery Enhanced Delivery System
Summary page 4
…utery-Enhanced Delivery System 510(k) Numbers: K181905, K192043 Device Common Name: Pancreatic drainage stent and delivery system &…
Boston Scientific Corporation2019—

Also cleared against K181905: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252648Niti-S SPAXUS StentTaewoong Medical Co., Ltd.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 3 companies; a new generation was cleared every 1.2 years on median.
  • 2 of the 13 ancestors have a recall of any class.
  • Of its descendants, K252648 (Taewoong Medical Co., Ltd., 2026) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K181905.

How does its category compare?

All PCU devices

PCU Pancreatic Stent, Covered, Metallic, Removable: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · PCU

1in 2022

2013: 12014: 12015: 32017: 12019: 22021: 12022: 12026 (partial year): 1
2007high 3 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PCU

46in 2015

2015: 46 days median
2007high 46 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PCU

6in 2020

2020: 6
2007high 6 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PCU

292in 2025

2014: 32015: 172016: 1012017: 952018: 902019: 1362020: 1442021: 1622022: 2082023: 2602024: 4162025: 292
2007high 416 (2024) · low 0 (2007)2025

MAUDE reports naming product code PCU, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20131—00
20141—03
2015346017
20160—0101
20171—095
20180—090
20192—0136
20200—6144
20211—0162
20221—0208
20230—0260
20240—0416
20250—0292
20261—0—

What is it indicated for?

The AXIOS™ Stent is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts > 6 cm in size, and symptomatic Walled Off Necrosis > 6 cm in size, that are adherent to the gastric or bowel wall. Once placed, the AXIOS™ Stent functions as an access port allowing passage of standard and therapeutic endoscopes to facilitate debridement, irrigation and cystoscopy. The Stent is intended for implantation up to 60 days and should be removed upon confirmation of pseudocyst or Walled-Off Necrosis resolution.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K220112: AXIOS Stent and Electrocautery-Enhanced Delivery System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K220112

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026